OvaScience Appoints Harald Stock to Board of Directors

OvaScience Appoints Harald Stock to Board of Directors

OvaScienceSM, (OTC: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, announced today the appointment of Harald F. Stock, Ph.D., Chief Executive Officer of the Grünenthal Group, to its Board of Directors.

Suggested Articles

Orum Therapeutics raised $30 million to expand the applications for for its cell-penetrating antibody technology.

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.